Skip to main content
. 2020 Mar 11;28(6):312–319. doi: 10.1007/s12471-020-01407-z

Fig. 2.

Fig. 2

DoPING-HFpEF study design. A complete clinical assessment is scheduled at the end of each treatment period. 6MWD 6-min walk distance, QoL quality of life, TTE transthoracic echocardiogram, MRI/MRS magnetic resonance imaging and magnetic resonance spectroscopy, RHC (exercise) right heart catheterisation